Wound care company Sanuwave Health announced that it entered into a business combination agreement with SEP Acquisition Corp. The merger with SEP, a special purpose acquisition company (SPAC), aims to create a Nasdaq-listed company. Upon the transaction’s completion, the combined company expects to operate under the Sanuwave name and the “SNWV” ticker. The proposed transaction […]
Sanuwave
Sanuwave appoints new CEO
Sanuwave recently announced it appointed Morgan Frank as chief executive officer, effective immediately. Frank has served 19 years as founder and principal of Manchester Management, Sanuwave’s largest outside shareholder, and has served as chair of the Sanuwave board of directors since August 2022. Former CEO Kevin Richardson will remain on the board of directors of […]
MedTech 100 roundup: Up-and-down week for industry
Medtech stocks highlighted the topsy-turvy nature of the market last week, but ultimately finished the seven days nearly unchanged. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 89.77 points at the end of last week (Aug. 14). Overall, medtech stocks saw a 0.13% increase from the […]
Sanuwave completes Celarity buy
Sanuwave Health (OTC:SNWV) announced that it completed its acquisition of Celularity’s UltraMist ultrasound healing therapy platform. In June, the companies announced an exclusive agreement for the purchase, which includes exclusive partnership rights for Celularity’s wound care biologic products. Celularity develops allogeneic cellular therapies engineered from postpartum human placenta, in cancer, infectious disease and degenerative disease. Along with the […]
Sanuwave announces intent to acquire Celularity’s UltraMist
Sanuwave Health (OTC:SNWV) announced that it entered into an exclusive agreement to acquire Celularity’s UltraMist ultrasound healing therapy platform. The non-binding letter of intent includes the acquisition of UltraMist and exclusive partnership rights for Celularity’s wound care biologic products, according to a news release. Celularity develops allogeneic cellular therapies engineered from postpartum human placenta, in cancer, […]
Sanuwave partners with The Mobile Health Company
Sanuwave Health announced that it is partnering with its former president’s new business, The Mobile Health Company (MHC). Former Sanuwave president Shri Parikh launched MHC as a mobile solution for wound care and other treatments to be streamlined directly to a patient’s home setting. In launching MHC, Shri is resigning from Sanuwave, but will remain […]
Sanuwave confirms acting CEO Richardson as company head | Personnel Moves – December 12, 2018
Sanuwave said late last month that it lifted acting CEO and board chair Kevin Richardson to a permanent position in the corner office. Richardson joined the Suwanee, Ga.-based company in 2009 as board chair, and has served as acting CEO since 2014. He also served as managing partner of investment management firm Prides Capital from […]
FDA clears device that treats diabetic foot ulcers for market
The FDA announced today that it has cleared the Dermapace System diabetic foot ulcer treatment device for market. Dermapace System, created by Sanuwave, is the first shockwave device to treat foot ulcers caused by diabetes. “Diabetes is the leading cause of lower limb amputations,” Binita Ashar, director of the division of surgical devices in FDA’s […]
7 medtech stories we missed this week: Sept. 29, 2017
From EOI getting FDA clearance to Sanuwave’s new joint venture agreement, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. EOI wins FDA nod for FLXfit15 expandable cage EOI announced in a Sept. 28 press release that it has received FDA 510(k) clearance for its FLXfit 15. The clearance […]
7 medtech stories we missed this week: Aug. 18, 2017
From Nemaura’s new Oceania distribution deal to Sanuwave’s promissory note expansion, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Nemaura inks Oceania distribution deal for SugarBeat patch Nemaura announced in an Aug. 15 press release that it has signed a non-binding distribution deal with Device Technologies for […]